Loss of Endothelial FTO Antagonizes Obesity-Induced Metabolic and Vascular Dysfunction
- 17 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 126 (2) , 232-242
Abstract
Rationale: Increasing prevalence of obesity and its associated risk with cardiovascular diseases demands a better understanding of the contribution of different cell types within this complex disease for developing new treatment options. Previous studies could prove a fundamental role of FTO (fat mass and obesity-associated protein) within obesity; however, its functional role within different cell types is less understood. Objectives: We identify endothelial FTO as a previously unknown central regulator of both obesity-induced metabolic and vascular alterations. Methods and Results: We generated endothelial Fto -deficient mice and analyzed the impact of obesity on those mice. While the loss of endothelial FTO did not influence the development of obesity and dyslipidemia, it protected mice from high-fat diet–induced glucose intolerance and insulin resistance by increasing AKT (protein kinase B) phosphorylation in endothelial cells and skeletal muscle. Furthermore, loss of endothelial FTO prevented the development of obesity-induced hypertension by preserving myogenic tone in resistance arteries. In Fto -deficient arteries, microarray analysis identified upregulation of L-Pgds with significant increases in prostaglandin D 2 levels. Blockade of prostaglandin D 2 synthesis inhibited the myogenic tone protection in resistance arteries of endothelial Fto -deficient mice on high-fat diet; conversely, direct addition of prostaglandin D 2 rescued myogenic tone in high-fat diet–fed control mice. Myogenic tone was increased in obese human arteries with FTO inhibitors or prostaglandin D 2 application. Conclusions: These data identify endothelial FTO as a previously unknown regulator in the development of obesity-induced metabolic and vascular changes, which is independent of its known function in regulation of obesity.Keywords
This publication has 37 references indexed in Scilit:
- Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling PathwayCell Metabolism, 2017
- Hemoglobin α/eNOS Coupling at Myoendothelial Junctions Is Required for Nitric Oxide Scavenging During VasoconstrictionArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membraneMolecular Metabolism, 2014
- Microvascular dysfunction as a link between obesity, insulin resistance and hypertensionDiabetes Research and Clinical Practice, 2014
- Obesity‐related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of theThe Obesity Societyand theAmerican Society of HypertensionObesity, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Vascular Structural and Functional Changes in Type 2 Diabetes MellitusCirculation, 2002
- Fluid Shear Stress Induces Lipocalin-Type Prostaglandin D 2 Synthase Expression in Vascular Endothelial CellsCirculation Research, 2000